Study #2022-0603
Feasibility and clinical utility of cell-free DNA (cfDNA) in identifying actionable alterations and minimal residual disease for lymphoma patients across community centers in Texas.
MD Anderson Study Status
Enrolling
Treatment Agent
Diagnostic Test: cell-free DNA
Description
To test the feasibility of collecting cell-free DNA (cfDNA) samples from DLBCL patients before and after treatment. cfDNA is DNA traveling in your blood outside of a cell and is easily collected from blood samples drawn using the vein puncture method.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Lymphoma
Study phase:
Not applicable
Physician name:
Christopher Flowers
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.